Aptatek BioSciences
Pre-clinicalAptatek BioSciences, Inc., is developing game-changing home monitoring tools for chronic disease patients and medication management. The Aptatek system combines its proprietary aptamer assay approach with a handheld, smartphone-based test platform. The company has already received Breakthrough Device designation by the FDA, for its first product - a phenylketonuria (PKU) monitoring test.
About
Aptatek BioSciences, Inc., is developing game-changing home monitoring tools for chronic disease patients and medication management. The Aptatek system combines its proprietary aptamer assay approach with a handheld, smartphone-based test platform. The company has already received Breakthrough Device designation by the FDA, for its first product - a phenylketonuria (PKU) monitoring test.
Funding History
2Total raised: $3.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile